Albany Molecular completes purchase of Indian manufacturing sites
The plants, in Aurangabad and Navi, were purchased from the Runwal Group, and also come with additional land for expansion. AMRI, an Albany, N.Y., drug discovery company, already has said it plans to invest $15 million over the next three years to expand and upgrade the Aurangabad facility.
Comments